Lantheus Holdings, Inc. (LNTH)
Largest Insider Buys in Sector
LNTH Stock Price History Chart
LNTH Stock Performance
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
Insider Activity of Lantheus Holdings, Inc.
Over the last 12 months, insiders at Lantheus Holdings, Inc. have bought $0 and sold $16.96M worth of Lantheus Holdings, Inc. stock.
On average, over the past 5 years, insiders at Lantheus Holdings, Inc. have bought $141,200 and sold $13.29M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,000 shares for transaction amount of $18,600 was made by Maeusli Heinz Christoph (director) on 2021‑03‑05.
List of Insider Buy and Sell Transactions, Lantheus Holdings, Inc.
| 2024-06-13 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $79.77 | $27,202 | +1.31% | |
| 2024-05-31 | Sale | Blanchfield Paul | President | 1,179 0.0017% | $80.82 | $95,287 | -0.89% | |
| 2024-05-30 | Sale | Niedzwiecki Daniel | See Remarks | 12,873 0.0184% | $79.86 | $1.03M | +0.77% | |
| 2024-05-28 | Sale | McHugh Julie | director | 2,500 0.0036% | $78.50 | $196,250 | +2.00% | |
| 2024-05-28 | Sale | Maeusli Heinz Christoph | director | 18,373.33 0.0264% | $79.19 | $1.45M | +2.00% | |
| 2024-05-13 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $76.89 | $26,219 | +3.35% | |
| 2024-04-15 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $61.24 | $20,883 | +31.29% | |
| 2024-03-15 | Sale | Marshall Robert J. Jr. | CFO and Treasurer | 20,000 0.0301% | $60.00 | $1.2M | +29.91% | |
| 2024-03-13 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $60.48 | $20,624 | +26.48% | |
| 2024-03-07 | Sale | Blanchfield Paul | President | 18,023 0.026% | $61.96 | $1.12M | +7.67% | |
| 2024-03-06 | Sale | LENO SAM R | director | 2,045 0.0031% | $63.50 | $129,857 | +8.71% | |
| 2024-03-05 | Sale | LENO SAM R | director | 2,045 0.003% | $64.62 | $132,148 | +4.38% | |
| 2024-03-04 | Sale | Heino Mary Anne | director | 93,863 0.1367% | $65.31 | $6.13M | +2.32% | |
| 2024-03-04 | Sale | LENO SAM R | director | 22,389 0.0327% | $65.42 | $1.46M | +2.32% | |
| 2024-02-13 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $55.31 | $18,861 | +19.11% | |
| 2024-01-16 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $56.01 | $19,099 | +13.52% | |
| 2023-12-15 | Sale | Marshall Robert J. Jr. | CFO and Treasurer | 10,000 0.015% | $78.24 | $782,400 | -17.69% | |
| 2023-12-13 | Sale | Sabens Andrea | Chief Accounting Officer | 341 0.0005% | $75.62 | $25,786 | -18.25% | |
| 2023-11-16 | Sale | Blanchfield Paul | President | 1,500 0.0022% | $67.96 | $101,940 | -5.33% | |
| 2023-11-13 | Sale | Heino Mary Anne | CEO | 11,780 0.017% | $63.72 | $750,611 | -0.39% |
Insider Historical Profitability
| Heino Mary Anne | CEO | 251643 0.4639% | $78.52 | 0 | 37 | |
| Marshall Robert J. Jr. | CFO and Treasurer | 113749 0.1506% | $78.52 | 0 | 23 | |
| Blanchfield Paul | President | 101498 0.1294% | $78.52 | 0 | 14 | |
| Niedzwiecki Daniel | See Remarks | 80244 0.0968% | $78.52 | 0 | 11 | |
| Sabens Andrea | Chief Accounting Officer | 62557 0.0858% | $78.52 | 0 | 31 | |
| LENO SAM R | director | 57937 0.0817% | $78.52 | 0 | 9 | |
| McHugh Julie | 28617 0.0386% | $78.52 | 0 | 7 | ||
| Maeusli Heinz Christoph | director | 23340 0.0237% | $78.52 | 8 | 1 | +41.74% |
| Venkataraman Sriram | 1846996 2.6968% | $78.52 | 0 | 2 | ||
| Crowley John W. | CFO | 138656 0.2024% | $78.52 | 0 | 2 | |
| Avista Capital Partners GP, LLC | 10 percent owner | 122492 0.1788% | $78.52 | 0 | 7 | |
| DUFFY MICHAEL P | SVP and General Counsel | 109472 0.1598% | $78.52 | 0 | 24 | |
| Bolla John J. | Chief Operations Officer | 102440 0.1496% | $78.52 | 0 | 7 | |
| Orlandi Cesare | Chief Medical Officer | 68483 0.1% | $78.52 | 0 | 13 | |
| Montagut Etienne | Chief Business Officer | 67254 0.0982% | $78.52 | 0 | 15 | |
| Walker Carol | Senior Vice President, Quality | 64899 0.0948% | $78.52 | 0 | 4 | |
| Healey Timothy G | SVP, Commercial | 60886 0.0889% | $78.52 | 0 | 3 | |
| Robertson A Frederick | director | 40402 0.059% | $78.52 | 0 | 2 | |
| Burgstahler David F | director | 38269 0.0559% | $78.52 | 0 | 17 | |
| Ber Gerard | 32703 0.0477% | $78.52 | 0 | 1 | ||
| Molnar Istvan | Chief Medical Officer | 25130 0.0367% | $78.52 | 0 | 1 | |
| MARKISON BRIAN A | 19318 0.0282% | $78.52 | 0 | 17 | ||
| SCHAFFER DERACE L | director | 16994 0.0248% | $78.52 | 0 | 9 | |
| Pruden Gary J | director | 10072 0.0147% | $78.52 | 0 | 1 | |
| Thrall James H | director | 9764 0.0143% | $78.52 | 0 | 1 | |
| Baylor-Henry Minnie | director | 16 0% | $78.52 | 0 | 1 |
Institutional Investor Ownership
| BlackRock | $524.83M | 12.17 | 8.43M | -0.41% | -$2.14M | 0.01 | |
| The Vanguard Group | $458.27M | 10.62 | 7.36M | +5.59% | +$24.26M | 0.01 | |
| Janus Henderson | $238.95M | 5.54 | 3.84M | -2.75% | -$6.74M | 0.13 | |
| State Street | $154.96M | 3.59 | 2.49M | +3.79% | +$5.66M | 0.01 | |
| Westfield Capital Management Co Lp | $121.87M | 2.83 | 1.96M | +25.26% | +$24.57M | 0.64 | |
| Geode Capital Management | $98.41M | 2.28 | 1.58M | +3.75% | +$3.56M | 0.01 | |
| Farallon Capital | $92.32M | 2.14 | 1.48M | +595.28% | +$79.04M | 0.65 | |
| Reinhart Partners Inc | $91.52M | 2.12 | 1.47M | +8.41% | +$7.1M | 3.73 | |
| T. Rowe Price | $86.47M | 2 | 1.39M | -14.97% | -$15.23M | 0.01 | |
| Macquarie Group | $82.22M | 1.91 | 1.32M | -1.71% | -$1.43M | 0.07 | |
| Dimensional Fund Advisors | $75.96M | 1.76 | 1.22M | +6.4% | +$4.57M | 0.02 | |
| Fidelity Investments | $73.6M | 1.71 | 1.18M | -49.27% | -$71.49M | 0.01 | |
| Hood River Capital Management LLC | $69.84M | 1.62 | 1.12M | -6.24% | -$4.65M | 1.56 | |
| Invesco | $60.76M | 1.41 | 976,186 | -12.41% | -$8.61M | 0.01 | |
| Millennium Management LLC | $56.79M | 1.32 | 912,428 | +457.59% | +$46.6M | 0.04 | |
| Northern Trust | $54.49M | 1.26 | 875,508 | -9.69% | -$5.85M | 0.01 | |
| Silvercrest Asset Management Group Inc | $50.63M | 1.17 | 813,395 | -3.43% | -$1.8M | 0.35 | |
| Charles Schwab | $50.55M | 1.17 | 812,131 | -3.31% | -$1.73M | 0.01 | |
| T Rowe Price Investment Management Inc | $47.66M | 1.11 | 765,747 | -25.39% | -$16.22M | 0.03 | |
| Nuveen | $43.07M | 1 | 691,961 | -3.15% | -$1.4M | 0.01 | |
| Boston Partners | $42.7M | 0.98 | 681,281 | +21.2% | +$7.47M | 0.05 | |
| Bank of America | $40.97M | 0.95 | 658,209 | +15.06% | +$5.36M | <0.01 | |
| Morgan Stanley | $39.95M | 0.93 | 641,921 | +4.01% | +$1.54M | <0.01 | |
| BNY Mellon | $39.64M | 0.92 | 636,814 | -8.71% | -$3.78M | 0.01 | |
| JPMorgan Chase | $35.41M | 0.82 | 568,873 | +6.71% | +$2.23M | <0.01 | |
| William Blair Investment Management | $34.84M | 0.81 | 559,834 | +0.56% | +$194,437.76 | 0.09 | |
| Private Capital Management LLC | $34.82M | 0.81 | 559,441 | +0.48% | +$166,180.80 | 3.98 | |
| LAZARD ASSET MANAGEMENT LLC | $34.42M | 0.8 | 553,057 | +1.77% | +$598,477.80 | 0.05 | |
| Portolan Capital Management | $32.72M | 0.76 | 525,742 | +23.05% | +$6.13M | 2.51 | |
| ClearBridge Investments | $32.44M | 0.75 | 521,240 | -3.26% | -$1.09M | 0.03 | |
| American Century Investments | $31.97M | 0.74 | 513,674 | -64.61% | -$58.38M | 0.02 | |
| LSV Asset Management | $31.2M | 0.72 | 501,303 | +72.99% | +$13.16M | 0.07 | |
| Avidity Partners Management Lp | $29.88M | 0.69 | 480,000 | +26.32% | +$6.22M | 1.08 | |
| Marshall Wace | $28.45M | 0.66 | 457,062 | +12.94% | +$3.26M | 0.04 | |
| AQR Capital | $27.95M | 0.66 | 454,354 | +1,108.29% | +$25.64M | 0.05 | |
| Man Group Plc | $25.86M | 0.6 | 415,420 | +1,920.72% | +$24.58M | 0.06 | |
| Candriam S C A | $25.32M | 0.59 | 406,753 | -15.8% | -$4.75M | 0.16 | |
| Goldman Sachs | $24.5M | 0.57 | 393,676 | +51.95% | +$8.38M | 0.01 | |
| Fuller & Thaler Asset Management, Inc. | $24.24M | 0.56 | 389,390 | New | +$24.24M | 0.11 | |
| Franklin Templeton Investments | $23.2M | 0.54 | 372,797 | +1,808.74% | +$21.99M | 0.01 | |
| HERITAGE ASSET MANAGEMENT INC | $21.69M | 0.52 | 360,886 | -4% | -$904,595.37 | 0.11 | |
| Gilder Gagnon Howe & Co. LLC | $22.41M | 0.52 | 360,128 | -0.55% | -$123,297.44 | 0.28 | |
| Loomis, Sayles & Company | $21.05M | 0.49 | 338,248 | -20.38% | -$5.39M | 0.03 | |
| Citadel Advisors LLC | $20.55M | 0.48 | 330,186 | -62.42% | -$34.13M | 0.01 | |
| Royal Bank of Canada | $18.16M | 0.42 | 291,682 | +9.41% | +$1.56M | <0.01 | |
| Qube Research & Technologies | $17.4M | 0.4 | 279,586 | +10,235.9% | +$17.23M | 0.02 | |
| Comerica | $16.62M | 0.39 | 267,040 | +10.33% | +$1.56M | 0.07 | |
| Canada Pension Plan Investment Board | $15.85M | 0.37 | 254,600 | +96.75% | +$7.79M | 0.02 | |
| Federated Hermes | $15.27M | 0.35 | 245,356 | +1,938.18% | +$14.52M | 0.04 | |
| Ameriprise Financial | $15.28M | 0.35 | 245,689 | +4.41% | +$645,590.89 | <0.01 |